{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T08:29:26Z","timestamp":1793521766302,"version":"4.5.0"},"reference-count":51,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2016,6,1]],"date-time":"2016-06-01T00:00:00Z","timestamp":1464739200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["oto.theclinics.com","clinicalkey.jp","clinicalkey.com","clinicalkey.es","theclinics.com","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Otolaryngologic Clinics of North America"],"published-print":{"date-parts":[[2016,6]]},"DOI":"10.1016\/j.otc.2016.02.010","type":"journal-article","created":{"date-parts":[[2016,6,4]],"date-time":"2016-06-04T01:58:04Z","timestamp":1465005484000},"page":"639-654","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":41,"title":["Treatment of Hereditary Hemorrhagic Telangiectasia\u2013Related Epistaxis"],"prefix":"10.1016","volume":"49","author":[{"given":"Nathan B.","family":"Sautter","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Timothy L.","family":"Smith","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.otc.2016.02.010_bib1","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1002\/ajmg.1320320302","article-title":"Age-related clinical profile of hereditary hemorrhagic telangiectasia in an epidemiologically recruited population","volume":"32","author":"Plauchu","year":"1989","journal-title":"Am J Med Genet"},{"key":"10.1016\/j.otc.2016.02.010_bib2","first-page":"818","article-title":"Patients with hereditary hemorrhagic telangiectasia have increased plasma levels of vascular endothelial growth factor and transforming growth factor-beta 1 as well as high ALK1 tissue expression","volume":"90","author":"Sadick","year":"2005","journal-title":"Haematologica"},{"key":"10.1016\/j.otc.2016.02.010_bib3","doi-asserted-by":"crossref","first-page":"598","DOI":"10.1002\/humu.9421","article-title":"Distribution of ENG and ACVRL1 (ALK1) mutations in French HHT patients","volume":"27","author":"Lesca","year":"2006","journal-title":"Hum Mutat"},{"key":"10.1016\/j.otc.2016.02.010_bib4","doi-asserted-by":"crossref","first-page":"852","DOI":"10.1016\/S0140-6736(04)15732-2","article-title":"A\u00a0combined syndrome of juvenile polyposis and hereditary haemorrhagic telangiectasia associated with mutations in MADH4 (SMAD4)","volume":"363","author":"Gallione","year":"2004","journal-title":"Lancet"},{"key":"10.1016\/j.otc.2016.02.010_bib5","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1016\/j.ajhg.2013.07.004","article-title":"BMP9 mutations cause a vascular-anomaly syndrome with phenotypic overlap with hereditary hemorrhagic telangiectasia","volume":"93","author":"Wooderchak-Donahue","year":"2013","journal-title":"Am J Hum Genet"},{"key":"10.1016\/j.otc.2016.02.010_bib6","doi-asserted-by":"crossref","first-page":"1447","DOI":"10.1111\/j.1538-7836.2010.03860.x","article-title":"Hereditary hemorrhagic telangiectasia: from molecular biology to patient care","volume":"8","author":"Dupuis-Girod","year":"2010","journal-title":"J\u00a0Thromb Haemost"},{"key":"10.1016\/j.otc.2016.02.010_bib7","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1136\/jmg.2009.069013","article-title":"International guidelines for the diagnosis and management of hereditary haemorrhagic telangiectasia","volume":"48","author":"Faughnan","year":"2011","journal-title":"J\u00a0Med Genet"},{"key":"10.1016\/j.otc.2016.02.010_bib8","doi-asserted-by":"crossref","first-page":"1092","DOI":"10.1002\/lary.23893","article-title":"Lifestyle and dietary influences on nosebleed severity in hereditary hemorrhagic telangiectasia","volume":"123","author":"Silva","year":"2013","journal-title":"Laryngoscope"},{"key":"10.1016\/j.otc.2016.02.010_bib9","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1177\/194589240602000116","article-title":"New classification of nasal vasculature patterns in hereditary hemorrhagic telangiectasia","volume":"20","author":"Mahoney","year":"2006","journal-title":"Am J Rhinol"},{"issue":"8","key":"10.1016\/j.otc.2016.02.010_bib10","doi-asserted-by":"crossref","first-page":"640","DOI":"10.1002\/alr.21328","article-title":"Comparison of electrosurgical plasma coagulation and potassium-titanyl-phosphate laser photocoagulation for treatment of hereditary hemorrhagic telangiectasia-related epistaxis","volume":"4","author":"Luk","year":"2014","journal-title":"Int Forum Allergy Rhinol"},{"issue":"4","key":"10.1016\/j.otc.2016.02.010_bib11","doi-asserted-by":"crossref","first-page":"838","DOI":"10.1002\/lary.20818","article-title":"An epistaxis severity score for hereditary hemorrhagic telangiectasia","volume":"120","author":"Hoag","year":"2010","journal-title":"Laryngoscope"},{"key":"10.1016\/j.otc.2016.02.010_bib12","doi-asserted-by":"crossref","first-page":"E4","DOI":"10.1177\/014556131109000916","article-title":"Effectiveness of a nasal saline gel in the treatment of recurrent anterior epistaxis in anticoagulated patients","volume":"90","author":"Messick","year":"2011","journal-title":"Ear Nose Throat J"},{"key":"10.1016\/j.otc.2016.02.010_bib13","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1159\/000276741","article-title":"Effect of local tranexamic acid gel in the treatment of epistaxis","volume":"57","author":"Tibbelin","year":"1995","journal-title":"ORL J Otorhinolaryngol Relat Spec"},{"key":"10.1016\/j.otc.2016.02.010_bib14","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1046\/j.1365-2273.2001.00502.x","article-title":"A\u00a0prospective, single-blind, randomized controlled trial of antiseptic cream for recurrent epistaxis in childhood","volume":"26","author":"Kubba","year":"2001","journal-title":"Clin Otolaryngol"},{"key":"10.1016\/j.otc.2016.02.010_bib15","doi-asserted-by":"crossref","first-page":"820","DOI":"10.1002\/lary.23736","article-title":"Efficacy of a topical sesame\/rose geranium oil compound in patients with hereditary hemorrhagic telangiectasia associated epistaxis","volume":"123","author":"Reh","year":"2013","journal-title":"Laryngoscope"},{"key":"10.1016\/j.otc.2016.02.010_bib16","doi-asserted-by":"crossref","first-page":"644","DOI":"10.1002\/lary.21345","article-title":"Safety of intranasal bevacizumab (Avastin) treatment in patients with hereditary hemorrhagic telangiectasia-associated epistaxis","volume":"121","author":"Chen","year":"2010","journal-title":"Laryngoscope"},{"key":"10.1016\/j.otc.2016.02.010_bib17","doi-asserted-by":"crossref","first-page":"636","DOI":"10.1002\/lary.21415","article-title":"Efficacy of intranasal bevacizumab (Avastin) treatment in patients with hereditary hemorrhagic telangiectasia-associated epistaxis","volume":"121","author":"Karnezis","year":"2010","journal-title":"Laryngoscope"},{"key":"10.1016\/j.otc.2016.02.010_bib18","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1160\/TH09-07-0425","article-title":"Estrogen therapy for hereditary haemorrhagic telangiectasia (HHT): effects of raloxifene on endoglin and ALK1 expression in endothelial cells","volume":"103","author":"Albinana","year":"2010","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.otc.2016.02.010_bib19","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1097\/00005537-200404000-00021","article-title":"Hormonal and antihormonal therapy for epistaxis in hereditary hemorrhagic telangiectasia","volume":"114","author":"Jameson","year":"2004","journal-title":"Laryngoscope"},{"key":"10.1016\/j.otc.2016.02.010_bib20","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1002\/lary.20065","article-title":"Antiestrogen therapy for hereditary hemorrhagic telangiectasia: a doubleblind placebo-controlled clinical trial","volume":"119","author":"Yaniv","year":"2009","journal-title":"Laryngoscope"},{"key":"10.1016\/j.otc.2016.02.010_bib21","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1111\/j.0954-6820.1981.tb11614.x","article-title":"Estrogen treatment of hereditary hemorrhagic telangiectasia. A double-blind controlled clinical trial","volume":"209","author":"Vase","year":"1981","journal-title":"Acta Med Scand"},{"key":"10.1016\/j.otc.2016.02.010_bib22","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1016\/S0194-5998(03)00361-9","article-title":"Plasma surgery and topical estriol: effects on the nasal mucosa and long-term results in patients with Osler\u2019s disease","volume":"128","author":"Sadick","year":"2003","journal-title":"Otolaryngol Head Neck Surg"},{"issue":"3","key":"10.1016\/j.otc.2016.02.010_bib23","first-page":"375","article-title":"Topical timolol for the treatment of epistaxis in hereditary hemorrhagic telangiectasia","volume":"33","author":"Olitsky","year":"2012","journal-title":"Am J Rhinol"},{"issue":"4","key":"10.1016\/j.otc.2016.02.010_bib24","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1002\/alr.20053","article-title":"Office-based sclerotherapy for recurrent epistaxis due to hereditary hemorrhagic telangiectasia: a pilot study","volume":"1","author":"Boyer","year":"2011","journal-title":"Int Forum Allergy Rhinol"},{"issue":"1","key":"10.1016\/j.otc.2016.02.010_bib25","doi-asserted-by":"crossref","first-page":"80","DOI":"10.4193\/Rhino11.211","article-title":"Local sclerotherapy with polydocanol (Aethoxysklerol) for the treatment of epistaxis in Rendu-Osler-Weber or hereditary hemorrhagic telangiectasia (HHT): 15 years of experience","volume":"50","author":"Morais","year":"2012","journal-title":"Rhinology"},{"issue":"5","key":"10.1016\/j.otc.2016.02.010_bib26","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1002\/alr.21287","article-title":"Complications from office sclerotherapy for epistaxis due to hereditary hemorrhagic telangiectasia (HHT or Osler-Webe-Rendu)","volume":"4","author":"Hanks","year":"2014","journal-title":"Int Forum Allergy Rhinol"},{"key":"10.1016\/j.otc.2016.02.010_bib27","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1001\/archotol.1977.00780280027001","article-title":"Management of epistaxis in hereditary hemorrhagic telangiectasia: review of 80 cases","volume":"103","author":"McCaffrey","year":"1977","journal-title":"Arch Otolaryngol"},{"key":"10.1016\/j.otc.2016.02.010_bib28","doi-asserted-by":"crossref","first-page":"1397","DOI":"10.1288\/00005537-198712000-00004","article-title":"Neodyminum-YAG laser intranasal photocoagulation for hereditary hemorrhagic telangiectasia: an update report","volume":"97","author":"Kluger","year":"1987","journal-title":"Laryngoscope"},{"key":"10.1016\/j.otc.2016.02.010_bib29","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1002\/lsm.1900160303","article-title":"Laser safety","volume":"16","author":"Sliney","year":"1995","journal-title":"Lasers Surg Med"},{"key":"10.1016\/j.otc.2016.02.010_bib30","doi-asserted-by":"crossref","first-page":"182","DOI":"10.2500\/ajr.2008.22.3145","article-title":"The impact of septodermoplasty and potassium-titanyl-phosphate (KTP) laser therapy in the treatment of hereditary hemorrhagic telangiectasia-related epistaxis","volume":"22","author":"Harvey","year":"2008","journal-title":"Am J Rhinol"},{"key":"10.1016\/j.otc.2016.02.010_bib31","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1177\/194589240501900515","article-title":"Clinical strategy in hereditary hemorrhagic telangiectasia","volume":"19","author":"Kuhnel","year":"2005","journal-title":"Am J Rhinol"},{"key":"10.1016\/j.otc.2016.02.010_bib32","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1097\/00005537-200205000-00001","article-title":"Hereditary hemorrhagic telangiectasia: a review of 76 cases","volume":"112","author":"Shah","year":"2002","journal-title":"Laryngoscope"},{"key":"10.1016\/j.otc.2016.02.010_bib33","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1017\/S0022215100136370","article-title":"A\u00a0retrospective study of the role of the argon laser in the management of epistaxis secondary to hereditary haemorrhagic telangiectasia","volume":"111","author":"Lennox","year":"1997","journal-title":"J\u00a0Laryngol Otol"},{"key":"10.1016\/j.otc.2016.02.010_bib34","doi-asserted-by":"crossref","first-page":"1006","DOI":"10.1016\/j.otohns.2005.12.019","article-title":"The utility of bipolar electrocautery in hereditary hemorrhagic telangiectasia","volume":"134","author":"Ghaheri","year":"2006","journal-title":"Otolaryngol Head Neck Surg"},{"key":"10.1016\/j.otc.2016.02.010_bib35","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1097\/00005537-200404000-00037","article-title":"Inferior turbinectomy in conjunction with septodermoplasty for patients with hereditary hemorrhagic telangiectasia","volume":"114","author":"Ross","year":"2004","journal-title":"Laryngoscope"},{"key":"10.1016\/j.otc.2016.02.010_bib36","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1097\/00006534-197208000-00002","article-title":"Management of epistaxis in Osler-Weber-Rendu disease: recurrence of telangiectases within a nasal skin graft","volume":"50","author":"McCabe","year":"1972","journal-title":"Plast Reconstr Surg"},{"key":"10.1016\/j.otc.2016.02.010_bib37","doi-asserted-by":"crossref","first-page":"312","DOI":"10.2500\/ajr.2007.21.3017","article-title":"Septectomy and septal dermoplasty for the treatment of severe transfusion-dependent epistaxis in patients with hereditary hemorrhagic telangiectasia and septal perforation","volume":"21","author":"Lesnik","year":"2007","journal-title":"Am J Rhinol"},{"key":"10.1016\/j.otc.2016.02.010_bib38","doi-asserted-by":"crossref","first-page":"1174","DOI":"10.1288\/00005537-199409000-00023","article-title":"Modified Young\u2019s procedure for refractory epistaxis due to hereditary hemorrhagic telangiectasia","volume":"104","author":"Gluckman","year":"1994","journal-title":"Laryngoscope"},{"key":"10.1016\/j.otc.2016.02.010_bib39","doi-asserted-by":"crossref","first-page":"754","DOI":"10.1017\/S0022215100128026","article-title":"Hereditary hemorrhagic telangiectasia: Young\u2019s procedure","volume":"108","author":"Hosni","year":"1994","journal-title":"J\u00a0Laryngol Otol"},{"key":"10.1016\/j.otc.2016.02.010_bib40","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1017\/S0022215100136369","article-title":"Closure of the nasal cavities in the treatment of refractory hereditary haemorrhagic telangiectasia","volume":"111","author":"Lund","year":"1997","journal-title":"J\u00a0Laryngol Otol"},{"key":"10.1016\/j.otc.2016.02.010_bib41","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1002\/alr.21099","article-title":"Management of severe epistaxis after Young\u2019s procedure: a case report","volume":"3","author":"Ting","year":"2013","journal-title":"Int Forum Allergy Rhinol"},{"issue":"4","key":"10.1016\/j.otc.2016.02.010_sref42","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1002\/alr.20053","article-title":"Office-based sclerotherapy for recurrent epistaxis due to hereditary hemorrhagic telangiectasia: a pilot study","volume":"1","author":"Boyer","year":"2011","journal-title":"Int Forum Allergy Rhinol"},{"key":"10.1016\/j.otc.2016.02.010_sref43","unstructured":"This article provides the first description of in-office Sotradecol sclerotherapy treatment for HHT-related epistaxis, which has become a popular in-office treatment option for HHT patients over the past 5\u00a0years."},{"key":"10.1016\/j.otc.2016.02.010_sref44","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1136\/jmg.2009.069013","article-title":"International guidelines for the diagnosis and management of hereditary haemorrhagic telangiectasia","volume":"48","author":"Faughnan","year":"2011","journal-title":"J\u00a0Med Genet"},{"key":"10.1016\/j.otc.2016.02.010_sref45","unstructured":"This article summarizes the expert consensus guidelines for diagnosis and HHT and provides recommendations for screening and other diagnostic studies."},{"key":"10.1016\/j.otc.2016.02.010_sref46","doi-asserted-by":"crossref","first-page":"182","DOI":"10.2500\/ajr.2008.22.3145","article-title":"The impact of septodermoplasty and potassium-titanyl-phosphate (KTP) laser therapy in the treatment of hereditary hemorrhagic telangiectasia-related epistaxis","volume":"22","author":"Harvey","year":"2008","journal-title":"Am J Rhinol"},{"key":"10.1016\/j.otc.2016.02.010_sref47","unstructured":"This article provides a good summary of both septodermoplasty and KTP laser treatment for HHT, and also provides some outcomes data."},{"issue":"4","key":"10.1016\/j.otc.2016.02.010_sref48","doi-asserted-by":"crossref","first-page":"838","DOI":"10.1002\/lary.20818","article-title":"An epistaxis severity score for hereditary hemorrhagic telangiectasia","volume":"120","author":"Hoag","year":"2010","journal-title":"Laryngoscope"},{"key":"10.1016\/j.otc.2016.02.010_sref49","unstructured":"This article summarizes the Epistaxis Severity Score, which is a validated questionnaire that is, useful for quantifying severity of nosebleeds in patients with HHT."},{"key":"10.1016\/j.otc.2016.02.010_sref50","doi-asserted-by":"crossref","first-page":"1092","DOI":"10.1002\/lary.23893","article-title":"Lifestyle and dietary influences on nosebleed severity in hereditary hemorrhagic telangiectasia","volume":"123","author":"Silva","year":"2013","journal-title":"Laryngoscope"},{"key":"10.1016\/j.otc.2016.02.010_sref51","unstructured":"This article provides the results of a large survey sent to patients with HHT inquiring about various dietary and lifestyle triggers for epistaxis."}],"container-title":["Otolaryngologic Clinics of North America"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0030666516000141?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0030666516000141?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,9,21]],"date-time":"2020-09-21T17:07:28Z","timestamp":1600708048000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0030666516000141"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,6]]},"references-count":51,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2016,6]]}},"alternative-id":["S0030666516000141"],"URL":"https:\/\/doi.org\/10.1016\/j.otc.2016.02.010","relation":{},"ISSN":["0030-6665"],"issn-type":[{"value":"0030-6665","type":"print"}],"subject":[],"published":{"date-parts":[[2016,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Treatment of Hereditary Hemorrhagic Telangiectasia\u2013Related Epistaxis","name":"articletitle","label":"Article Title"},{"value":"Otolaryngologic Clinics of North America","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.otc.2016.02.010","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}